Infectious Disease

[Comment] From paediatric rebound to adult redistribution: changing the epidemiology of group A Streptococcus after COVID-19 | ClinicLens

The post-pandemic epidemiology of Streptococcus pyogenes has largely been interpreted through the lens of the 2022–23 upsurge, when the incidence of scarlet fever and invasive group A Streptococcus (iGAS), increased across several European countries, particularly among children.

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.